Chronological ageing and photoageing of the human sebaceous gland

Citation
Cc. Zouboulis et A. Boschnakow, Chronological ageing and photoageing of the human sebaceous gland, CLIN EXP D, 26(7), 2001, pp. 600-607
Citations number
42
Categorie Soggetti
Dermatology
Journal title
CLINICAL AND EXPERIMENTAL DERMATOLOGY
ISSN journal
03076938 → ACNP
Volume
26
Issue
7
Year of publication
2001
Pages
600 - 607
Database
ISI
SICI code
0307-6938(200110)26:7<600:CAAPOT>2.0.ZU;2-I
Abstract
The human sebaceous gland undergoes both extrinsic and intrinsic ageing. Th e latter is associated with morphological changes and alteration in the seb aceous gland activity. The high androgen-dependent sebum secretion in neona tes falls during childhood, starts to rise again during puberty and reaches its maximum in young adults. While the number of sebaceous glands remains the same during life, sebum levels tend to decrease after menopause in fema les, whereas no major changes appear until the eighth decade of life in men . Reduced androgen levels in aged individuals lead to a slow cellular turno ver in the sebaceous glands resulting in hyperplasia of the facial sebaceou s glands in advanced age. Ultraviolet radiation and immune suppression (cyc losporin A with corticosteroids) represent cofactors for the development of sebaceous gland hyperplasia. Current molecular findings indicate that over expression of the ageing-associated gene Smad7 and parathormone-related pro tein correlate with sebaceous gland hyperplasia, whereas c-myc overexpressi on is associated with enhanced sebum production. On the other hand, down-re gulation of the mismatch repair genes hMLH-1 and hMSH-2 may promote the dev elopment of sebaceous gland carcinoma. In addition to spontaneous single tu mours, sebaceous gland carcinomas have been reported in immune-suppressed t ransplant. recipients (azathiorpine, cisplatin, cyclosporin A) and in assoc iation with the Muir-Torre syndrome. Microsatellite instability with a loss of the mismatch repair gene hMSH-2 has been detected in immune suppressed patients and under photo-induced DNA damage. Topical and systemic oestrogen s offer treatment options for skin xerosis in menopausal females. A combina tion of isotretinoin and interferon-a may prevent tumour development in pat ients with Muir-Torre syndrome.